Search Results

Ultrasound microbubble contrast agents: Application to therapy for peripheral vascular disease

Authors: Hu, Yi-zhou; Zhu, Jia-an; Jiang, Ye-ging; Hu, Bing

Source: Advances in Therapy, Volume 26, Number 4, April 2009 , pp. 425-434(10)

Publisher: Springer

Tolerability and safety of GS-101 eye drops, an antisense oligonucleotide to insulin receptor substrate-1: a `first in man' Phase I investigation

Authors: Kain, Hermann; Goldblum, David; Geudelin, Bernard; Thorin, Eric; Beglinger, Christoph

Source: British Journal of Clinical Pharmacology, Volume 68, Number 2, August 2009 , pp. 169-173(5)

Publisher: Blackwell Publishing

Bevacizumab (Avastin) in Ocular Processes Other Than Choroidal Neovascularization

Authors: Barkmeier, Andrew; Akduman, Levent

Source: Ocular Immunology and Inflammation, Volume 17, Number 2, April 2009 , pp. 109-117(9)

Publisher: Informa Healthcare

Ranibizumab for Diabetic Retinopathy

Authors: Rodriguez-Fontal, Monica; Alfaro, Virgil; Kerrison, John B.; Jablon, Eric P.

Source: Current Diabetes Reviews, Volume 5, Number 1, February 2009 , pp. 47-51(5)

Publisher: Bentham Science Publishers

Suppression of Retinal Neovascularization by shRNA Targeting HIF-1α

Authors: Xia, Xiao-bo; Xiong, Si-qi; Xu, Hui-zhuo; Jiang, Jian; Li, Yan

Source: Current Eye Research, Volume 33, Number 10, October 2008 , pp. 892-902(11)

Publisher: Informa Healthcare

Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population

Authors: Gotoh, Norimoto; Yamada, Ryo; Nakanishi, Hideo; Saito, Masaaki; Iida, Tomohiro; Matsuda, Fumihiko; Yoshimura, Nagahisa

Source: Clinical & Experimental Ophthalmology, Volume 36, Number 5, July 2008 , pp. 437-442(6)

Publisher: Blackwell Publishing

Angiogenesis in eye disease: immunity gained or immunity lost?

Authors: Ferguson, Thomas; Apte, Rajendra

Source: Seminars in Immunopathology, Volume 30, Number 2, April 2008 , pp. 111-119(9)

Publisher: Springer

Pegaptanib sodium for the treatment of age-related macular degeneration

Author: Apte, Rajendra S

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 3, February 2008 , pp. 499-508(10)

Publisher: Informa Healthcare

Pegaptanib sodium for the treatment of ocular vascular disease

Authors: Cunningham Jr, Emmett T; Adamis, Anthony P; Goldbaum, Mauro

Source: Expert Review of Ophthalmology, Volume 2, Number 1, February 2007 , pp. 45-60(16)

Publisher: Expert Reviews

Systemisches und intravitreales Bevacizumab (Avastin^®) bei neovaskulärer altersbezogener Makuladegeneration

Authors: Michels, S.; Prager, F.; Geitzenauer, W.; Lackner, B.; Sacu, S.; Weigert, G.; Kriechbaum, K.; Polak, K.; Georgopoulos, M.; Schmidt-Erfurth, U.

Source: Spektrum der Augenheilkunde, Volume 21, Number 3, July 2007 , pp. 154-159(6)

Publisher: Springer

Expression of Ubiquitin Carboxy-Terminal Hydrolase-L1 in Photocoagulated Human Retinal Pigment Epithelial Cells

Authors: Schacke, Wolfgang; Beck, Karl-Friedrich; Pfeilschifter, Josef; Hattenbach, Lars-Olof

Source: Current Eye Research, Volume 32, Number 4, April 2007 , pp. 367-372(6)

Publisher: Informa Healthcare

Intravitreal triamcinolone acetonide: potential complications

Authors: Vasconcelos-Santos, Daniel Vítor; Nehemy, Márcio B; Rich, Ryan McKay; Negrao, Silvana; Flynn, Harry W

Source: Expert Review of Ophthalmology, Volume 2, Number 6, December 2007 , pp. 987-999(13)

Publisher: Expert Reviews

RAGE and its Ligands in Retinal Disease

Authors: Barile, Gaetano R.; Schmidt, Ann M.

Source: Current Molecular Medicine, Volume 7, Number 8, December 2007 , pp. 758-765(8)

Publisher: Bentham Science Publishers

Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis

Authors: Hosseini, Hamid; Nejabat, Mahmood; Mehryar, Morsal; Yazdchi, Taher; Sedaghat, Ahad; Noori, Farajollah

Source: Clinical & Experimental Ophthalmology, Volume 35, Number 8, November 2007 , pp. 745-748(4)

Publisher: Blackwell Publishing

Emerging Therapies for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Authors: Emerson, M. Vaughn; Lauer, Andreas K.

Source: BioDrugs, Volume 21, Number 4, 2007 , pp. 245-257(13)

Publisher: Adis International

Ocular drug development - Future Directions

Author: Sherris, David

Source: Angiogenesis, Volume 10, Number 2, June 2007 , pp. 71-76(6)

Publisher: Springer

Combination therapy for the treatment of ocular neovascularization

Authors: Bradley, John; Ju, Meihua; Robinson, Gregory

Source: Angiogenesis, Volume 10, Number 2, June 2007 , pp. 141-148(8)

Publisher: Springer

Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases

Authors: NG, EUGENE W.M.; ADAMIS, ANTHONY P.

Source: Annals of the New York Academy of Sciences, Volume 1082, Number 1, October 2006 , pp. 151-171(21)

Publisher: Blackwell Publishing

Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases

Authors: NG, EUGENE W.M.; ADAMIS, ANTHONY P.

Source: Annals of the New York Academy of Sciences, Volume 1082, Number 1, October 2006 , pp. 151-171(21)

Publisher: Blackwell Publishing

Inhibition of Ocular Angiogenesis by Diced Small Interfering RNAs (siRNAs) Specific to Vascular Endothelial Growth Factor (VEGF)

Authors: Murata, Masatoshi; Takanami, Takako; Shimizu, Shinji; Kubota, Yosiko; Horiuchi, Saburo; Habano, Wataru; Ma, Jian-xing; Sato, Sanai

Source: Current Eye Research, Volume 31, Number 2, February 2006 , pp. 171-180(10)

Publisher: Informa Healthcare